Latest News
Featured News
Scancell to Present Clinical Data from the Ongoing Phase 2 SCOPE Trial of SCIB1 at 2025 AACR Annual Meeting
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
First patient dosed in Cohort 2 of the ModiFY Phase 1 clinical trial
Scancell to produce and clinically validate T cell redirecting bispecific antibodies
Phase 2 SCOPE trial of SCIB1 vaccine in metastatic melanoma patients expanded
First patient dosed in Modi-1 Phase 1 clinical trial
Modi-1 Phase 1/2 clinical trial open for recruitment
Broadening of COVIDITY Phase 1 clinical trial in South Africa
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.